Karen Tylee

1.2k total citations
45 papers, 704 citations indexed

About

Karen Tylee is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Karen Tylee has authored 45 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Physiology, 13 papers in Epidemiology and 12 papers in Rheumatology. Recurrent topics in Karen Tylee's work include Lysosomal Storage Disorders Research (40 papers), Trypanosoma species research and implications (12 papers) and Glycogen Storage Diseases and Myoclonus (11 papers). Karen Tylee is often cited by papers focused on Lysosomal Storage Disorders Research (40 papers), Trypanosoma species research and implications (12 papers) and Glycogen Storage Diseases and Myoclonus (11 papers). Karen Tylee collaborates with scholars based in United Kingdom, United States and Netherlands. Karen Tylee's co-authors include Jean Mercer, Heather J. Church, Robert Wynn, Simon Jones, Brian Bigger, Margaret J. Thornley, J. E. Wraith, Anne O’Meara, J. E. Wraith and Arunabha Ghosh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Human Molecular Genetics.

In The Last Decade

Karen Tylee

44 papers receiving 695 citations

Peers

Countries citing papers authored by Karen Tylee

Since Specialization

Citations

This map shows the geographic impact of Karen Tylee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Tylee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Tylee more than expected).

Fields of papers citing papers by Karen Tylee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Tylee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Tylee. The network helps show where Karen Tylee may publish in the future.

Co-authorship network of co-authors of Karen Tylee

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Tylee. A scholar is included among the top collaborators of Karen Tylee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Tylee. Karen Tylee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Iron metabolism and hematological abnormalities in adult patients affected with mucopolysaccharidoses 2025 ·Molecular Genetics and Metabolism Reports ·(unknown), (unknown), Reena Sharma, Simon Jones, Robert Wynn, Heather J. Church, Karen Tylee, Muzaffer Bilgin, Ana Jovanović, Peter Woolfson, Karolina M. Stępień	0
2	The use and performance of lyso-Gb3 for the diagnosis and monitoring of Fabry disease: A systematic literature review 2025 ·Molecular Genetics and Metabolism ·Uma Ramaswami, Michael L. West, Karen Tylee, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
3	Hepatomegaly and Splenomegaly: An Approach to the Diagnosis of Lysosomal Storage Diseases 2024 ·Journal of Clinical Medicine ·(unknown), Jessica I. Gold, James A. Cooper, Heather J. Church, Karen Tylee, (unknown), Sun Young Kim, Karolina M. Stępień	3
4	Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatment 2024 ·Molecular Genetics and Metabolism ·(unknown), Heather A. Brown, Heather J. Church, Christopher J. Kershaw, (unknown), Christine Egerton, James A. Cooper, Karen Tylee, (unknown), David Gokhale, Dipak Ram, (unknown), Michael W. Henderson, Brian Bigger, Simon Jones	6
5	Long-term outcomes in two adult siblings with Fucosidosis – Diagnostic odyssey and clinical manifestations 2023 ·Molecular Genetics and Metabolism Reports ·(unknown), Ian O. Ellis, (unknown), (unknown), Heather J. Church, Karen Tylee, (unknown), Richard Hackett, (unknown), (unknown), Christian J. Hendriksz, Andrew A. M. Morris, Simon Jones, Karolina M. Stępień	1
6	Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33A 2022 ·Human Mutation ·Elena Pavlova, Dorit Lev, Marina Michelson, Keren Yosovich, (unknown), Nicholas A. Bright, Paul T. Manna, Veronica Kane Dickson, Karen Tylee, Heather J. Church, J. Paul Luzio, Timothy M. Cox	10
7	Identification of patients with Fabry disease using routine pathology results: PATHFINDER (eGFR) study 2020 ·International Journal of Clinical Practice ·(unknown), Karen Tylee, (unknown), Anthony S. Wierzbicki	6
8	A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I 2020 ·Journal of Veterinary Internal Medicine ·Kiterie M. E. Faller, Alison E. Ridyard, Rodrigo Gutierrez‐Quintana, (unknown), Célia Kun‐Rodrigues, Tatiana Orme, Karen Tylee, Heather J. Church, Rita Guerreiro, José Brás	3
9	The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I 2020 ·Molecular Genetics and Metabolism ·Alexander Broomfield, Jason Sims, Jean Mercer, Pauline Hensman, Arunabha Ghosh, Karen Tylee, Karolina M. Stępień, (unknown), (unknown), Robert Wynn, N. B. Wright, Simon Jones, Stuart Wilkinson	5
10	Ex-Vivo Autologous Stem Cell Gene Therapy Clinical Trial for Mucopolysaccharidosis Type IIIA: Trial in Progress - NCT04201405 2020 ·Blood ·(unknown), Robert Wynn, Brian Bigger, Adrian J. Thrasher, Claire Booth, Karen Buckland, Natalia Izotova, Stewart Rust, Daniel Weisberg, Heather J. Church, (unknown), Karen Tylee, Ceri Jones, Helena Lee, (unknown), (unknown), Stuart Ellison, Simon Jones	6
11	Identification of patients with Pompé disease using routine pathology results: PATHFINDER (creatine kinase) study 2019 ·Journal of Clinical Pathology ·Tim Reynolds, Karen Tylee, (unknown), Anthony S. Wierzbicki	3
12	Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I 2019 ·Molecular Therapy — Methods & Clinical Development ·Arunabha Ghosh, Aiyin Liao, Claire O’Leary, Jean Mercer, Karen Tylee, Anu Goenka, Rebecca Holley, Simon Jones, Brian Bigger	10
13	I-Cell Disease (Mucolipidosis II): A Case Series from a Tertiary Paediatric Centre Reviewing the Airway and Respiratory Consequences of the Disease 2018 ·JIMD Reports ·(unknown), Stuart Wilkinson, Simon Jones, Karen Tylee, Alexander Broomfield, Iain Bruce	10
14	Maternal mosaicism for IDUA deletion clarifies recurrence risk in MPS I 2016 ·Human Genome Variation ·Catherine Breen, Jean Mercer, Simon Jones, Amir Jahić, Lesley Heptinstall, Karen Tylee, William G. Newman, Christian Beetz	8
15	Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10year combined experience of 2 centres 2016 ·Molecular Genetics and Metabolism ·Arunabha Ghosh, Weston P. Miller, Paul J. Orchard, Simon Jones, Jean Mercer, Heather J. Church, Karen Tylee, Troy C. Lund, Brian Bigger, Jakub Tolar, Robert Wynn	44
16	Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome 2015 ·Orphanet Journal of Rare Diseases ·Abhijit Pal, Eveline J. Langereis, (unknown), Jean Mercer, Heather J. Church, Karen Tylee, Robert Wynn, Frits A. Wijburg, Simon Jones, Iain Bruce, Brian Bigger	39
17	Mucopolysaccharidosis type II: Identification of 30 novel mutations among Latin American patients 2013 ·Molecular Genetics and Metabolism ·Ana Carolina Brusius‐Facchin, Ida Vanessa Döederlein Schwartz, (unknown), Márcia Gonçalves Ribeiro, Angelina Xavier Acosta, Dafne Dain Gandelman Horovitz, Isabella Lopes Monlleó, (unknown), Agnes Cristina Fett‐Conte, (unknown), (unknown), (unknown), Paulina Mabe, (unknown), (unknown), Karen Tylee, G. T. N. Besley, (unknown), Roberto Giugliani, Sandra Leistner‐Segal	33
18	Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy 2012 ·Haematologica ·(unknown), Brian Bigger, (unknown), Jean Mercer, Karen Tylee, Heather J. Church, Denise Bonney, Simon Jones, J. E. Wraith, Robert Wynn	40
19	Improved Metabolic Correction in Patients with Lysosomal Storage Disease Treated with Hematopoietic Stem Cell Transplant Compared with Enzyme Replacement Therapy 2009 ·The Journal of Pediatrics ·Robert Wynn, J. E. Wraith, Jean Mercer, Anne O’Meara, Karen Tylee, Margaret J. Thornley, Heather J. Church, Brian Bigger	95
20	Further cases of “neighbor” mutations in mucopolysaccharidosis type II 2006 ·American Journal of Medical Genetics Part A ·Ida Vanessa Döederlein Schwartz, (unknown), Karen Tylee, (unknown), Denise Norato, (unknown), G. T. N. Besley, (unknown), Úrsula da Silveira Matte, Roberto Giugliani, Sandra Leistner‐Segal	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact